Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis

Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study

(2021) Anton Ryzhov et al.   LANCET ONCOLOGY

Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approach

(2021) Patti E. Gravitt et al.   PREVENTIVE MEDICINE

Accelerating action on cervical screening in lower- and middle-income countries (LMICs) post COVID-19 era

(2021) Yin Ling Woo et al.   PREVENTIVE MEDICINE

2020 List of human papillomavirus assays Suitable for primary cervical cancer screening

(2021) M. Arbyn et al.   CLINICAL MICROBIOLOGY AND INFECTION

The IARC Perspective on Cervical Cancer Screening

(2021) Véronique Bouvard et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19 and the disruption of cancer screening programs: Key lessons for the recovery

(2021) Linda Rabeneck et al.   PREVENTIVE MEDICINE

Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities

(2021) Nicolas Wentzensen et al.   PREVENTIVE MEDICINE

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries

(2020) Marc Brisson et al.   LANCET

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

(2020) Karen Canfell et al.   LANCET

Commercially available molecular tests for human papillomaviruses: a global overview

(2020) M. Poljak et al.   CLINICAL MICROBIOLOGY AND INFECTION

Tackling cervical cancer in Europe amidst the COVID-19 pandemic

(2020) Marc Arbyn et al.   Lancet Public Health

Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries

(2020) Julia M. Lemp et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans

(2019) P.J. Maver et al.   CLINICAL MICROBIOLOGY AND INFECTION

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

(2019) Marc Arbyn et al.   Lancet Global Health

Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low- and lower-middle-income countries

(2017) Francesca Holme et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Cervical cancer prevention and treatment in Latin America

(2017) Melissa S. Lopez et al.   JOURNAL OF SURGICAL ONCOLOGY

Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement

(2016) Gretchen A Stevens et al.   LANCET

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

Planning cancer control in Latin America and the Caribbean

(2013) Paul E Goss et al.   LANCET ONCOLOGY

Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Central and Eastern Europe

(2013) Mario Poljak et al.   VACCINE

Comprehensive Control of Human Papillomavirus Infections and Related Diseases

(2013) F. Xavier Bosch et al.   VACCINE

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis

(2008) Michelle Howard et al.   CANCER CAUSES & CONTROL

Coverage of Cervical Cancer Screening in 57 Countries: Low Average Levels and Large Inequalities

(2008) Emmanuela Gakidou et al.   PLOS MEDICINE